| Pharmaceutical active ingredients: |
| Haloperidol |
| Available forms, composition and doses of Serenelfi: |
| N / A |
| Serenelfi medical category: |
| Human:AntipsychoticsButyrophenones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N05AD01 - Haloperidol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineLusofarmaco |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Septrin F | Sulfamethoxazole; Trimethoprim | GlaxoSmithKline; Sigma Pharmaceuticals |
| Septrin F Dispersable | Sulfamethoxazole; Trimethoprim | GlaxoSmithKline; Sigma Pharmaceuticals |
| Septrin Forte | Sulfamethoxazole; Trimethoprim | GlaxoSmithKline; Sigma Pharmaceuticals; Zuellig Pharma |
| Septrin Paediatric | Sulfamethoxazole; Trimethoprim | GlaxoSmithKline; Zuellig Pharma |
| Septrin S | Sulfamethoxazole; Trimethoprim | GlaxoSmithKline |
| Seretaide | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline |
| Seretide | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline; Firma Chun Cheong; Zuellig Pharma |
| Seretide Accuhaler | Albuterol Xinafoate; Fluticasone Propionate | GlaxoSmithKline; Allen & Hanburys; Firma Chun Cheong; Zuellig Pharma |
| Seretide CFC-free | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline |
| Seretide Diskus | Fluticasone Propionate; Salmeterol Xinafoate | GlaxoSmithKline; Zuellig Pharma |